First National Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
First National Advisers's LLY Position: Q1 2026 in Review
First National Advisers reduced its Eli Lilly (LLY) stake by 7.5% in Q1 2026, selling an estimated $791K and leaving 9,582 shares worth $8.81M. The position accounts for 1.29% of the portfolio, ranked #14.
First National Advisers first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $11.1M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- First National Advisers held 9,582 shares of Eli Lilly worth $8.81M as of Q1 2026.
- First National Advisers sold 780 Eli Lilly shares in Q1 2026, an estimated $791K.
- Eli Lilly made up 1.29% of First National Advisers's portfolio in Q1 2026, its #14 holding.
- First National Advisers first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
- First National Advisers's Eli Lilly position peaked at $11.1M in Q4 2025.
- 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on First National Advisers's 13F filing for Q1 2026, filed 8 May 2026.